Skip to content

The Safety and Efficacy of Epidural Oxycodone

The Safety and Efficacy of Epidural Oxycodone

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02573909
Acronym
epioksipanu
Enrollment
100
Registered
2015-10-12
Start date
2015-01-01
Completion date
2023-12-31
Last updated
2023-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Brief summary

There are conflicting results in earlier studies concerning the safety and efficacy of epidural oxycodone. In a study by Bäcklund and colleagues, epidural oxycodone was as effective as intravenous oxycodone, so they did not recommend epidural use of oxycodone. In another study, Yanagidate and Dohi reported that oxycodone was as effective in pain treatment with double dose compared to epidural morphine. In our previous study, epidural oxycodone provided safe and effective pain relief when compared to intravenous oxycodone. In the present study, the aim was to compare the efficacy and safety of epidural or intravenous oxycodone in patients undergoing elective gynecological surgery with planned epidural pain treatment.

Interventions

DRUGOxycodone intravenously

Oxycodone intravenously 0,1mg/kg

DRUGOxycodone epidurally

Oxycodone 0,1 mg epidurally

Sponsors

Admescope Ltd
CollaboratorINDUSTRY
Kuopio University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

similar syringes equal amount of drug

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Planned gynecological lower abdomen surgery with epidural pain treatment * Informed consent obtained

Exclusion criteria

* Planned surgery under regional anesthesia * contraindication to the study drug * contraindication to the lumbar puncture * Contraindication to oxycodone * Pregnancy or lactation * no informed consent

Design outcomes

Primary

MeasureTime frameDescription
amount of rescue medicinefrom zero hours up to four hoursThe amount of rescue pain medication given after study drug administration up to four hours

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026